Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients

References

• Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007;26: 681–6.
   PubMed Web of Science ®Google Scholar
• Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003;22:258–66.
   PubMed Web of Science ®Google Scholar
• Sole A, Salavert M. Fungal infections after lung transplantation. Transplant Rev (Orlando) 2008;22:89–104.
   PubMedGoogle Scholar
• Vogeser M, Wanders A, Haas A, Ruckdeschel G. A four-year review of fatal aspergillosis. Eur J Clin Microbiol Infect Dis 1999;18:42–5.
   PubMedGoogle Scholar
• Garantziotis S, Palmer SM. An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome. Am J Transplant 2009;9: 1705–6.
   PubMedGoogle Scholar
• Weigt SS, Elashoff RM, Huang C, Ardehali A, Gregson AL, Kubak B, . Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009;9:1903–11.
   PubMed Web of Science ®Google Scholar
• Iversen M, Burton CM, Vand S, Skovfoged L, Carlsen J, Milman N, . Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007;26:879–86.
   PubMed Web of Science ®Google Scholar
• Cadena J, Levine DJ, Angel LF, Maxwell PR, Brady R, Sanchez JF, . Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness. Am J Transplant 2009;9:2085–91.
   PubMed Web of Science ®Google Scholar
• Covarrubias MB, Milstone AP. An overview of fungal prophylaxis in lung transplantation. [Miscellaneous]. Curr Opin Organ Transplant 2005;10:227–32.
   Web of Science ®Google Scholar
• Dummer JS, Lazariashvilli N, Barnes J, Ninan M, Milstone AP. A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 2004;23:1376–81.
   PubMedGoogle Scholar
• Husain S, Zaldonis D, Kusne S, Kwak EJ, Paterson DL, McCurry KR. Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006;8:213–8.
   PubMedGoogle Scholar
• Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005;18:44–69.
   PubMed Web of Science ®Google Scholar
• Burton CM, Milman N, Carlsen J, Arendrup H, Eliasen K, Andersen CB, . The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart–lung transplantation. J Heart Lung Transplant 2005;24: 1834–43.
   PubMed Web of Science ®Google Scholar
• Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, . A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 2011;30: 361–74.
   PubMedGoogle Scholar
• Comparison of two proportions. 2011. Available at: http://www.statpages.org (accessed 18 December 2011).
   Google Scholar
• Sole A, Morant P, Salavert M, Peman J, Morales P. Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect 2005;11:359–65.
   PubMed Web of Science ®Google Scholar
• Husain S, Paterson DL, Studer S, Pilewski J, Crespo M, Zaldonis D, . Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006;6:3008–16.
   PubMed Web of Science ®Google Scholar
• Gordon SM, Avery RK. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transpl Infect Dis 2001;3:161–7.
   PubMedGoogle Scholar
• Mattner F, Chaberny IF, Weissbrodt H, Fischer S, Gastmeier P, Haubitz B, . [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole]. Mycoses 2005;48(Suppl 1):51–5.
   PubMedGoogle Scholar
• Forestier E, Remy V, Lesens O, Martinot M, Hansman Y, Eisenmann B, . A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole. Eur J Clin Microbiol Infect Dis 2005;24:347–9.
   PubMedGoogle Scholar
• Wieland T, Liebold A, Jagiello M, Retzl G, Birnbaum DE. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation. J Heart Lung Transplant 200524:102–4.
   PubMedGoogle Scholar
• Neoh CF, Snell GI, Kotsimbos T, Levvey B, Morrissey CO, Slavin MA, . Antifungal prophylaxis in lung transplantation—a world-wide survey. Am J Transplant 2011;11:361–6.
   PubMedGoogle Scholar
• Vadnerkar A, Clancy CJ, Celik U, Yousem SA, Mitsani D, Toyoda Y, . Impact of mold infections in explanted lungs on outcomes of lung transplantation. Transplantation 2010;89: 253–60.
   PubMed Web of Science ®Google Scholar